Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.
Yuthavong Y, Tarnchompoo B, Vilaivan T, Chitnumsub P, Kamchonwongpaisan S, Charman SA, McLennan DN, White KL, Vivas L, Bongard E, Thongphanchang C, Taweechai S, Vanichtanankul J, Rattanajak R, Arwon U, Fantauzzi P, Yuvaniyama J, Charman WN, Matthews D.
Yuthavong Y, et al. Among authors: tarnchompoo b.
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16823-8. doi: 10.1073/pnas.1204556109. Epub 2012 Oct 3.
Proc Natl Acad Sci U S A. 2012.
PMID: 23035243
Free PMC article.